Overview

Aspiration and Biopsy Needles Market Introduction: Aspiration and Biopsy Needles Market is estimated to value over USD 1.19 billion by 2027 end and register a CAGR of over 7% during the forecast period 2020 to 2027.

The global market is predicted to witness a surge as there is a rise in the occurrences of cancer, favorable sanctions by global health and government organizations along with a greater tendency to opt for diagnostic procedures which are minimally invasive.

Biopsy performed on the breast involves the removal of tissues and cells in certain areas of the breast that are vulnerable to diseases such as cancer. These tissues and cells are examined under a microscope to identify potential chances of cancer. When a hollow needle is inserted for the purpose of removing tissue samples from the breast, then it is called a core needle biopsy. Core needle biopsy is carried out for the detection of any lump or mass or any other suspicious spots which is identified after imaging testing or mammogram. In the case of biopsy that entails fine needles, there is also a removal of cells potentially cancerous lumps in the breast. The needle that is used for performing the fine needle biopsy happens to be thinner in comparison to the needle used in the biopsy of the core needle.

There are different kinds of biopsies which includes vacuum-assisted biopsy, core needle biopsy, shave biopsy, image guided biopsy, punch biopsy, excisional biopsy, incisional biopsy, fine needle aspiration, endoscopic biopsy, bone marrow biopsy and bone marrow aspiration. Two primary types of biopsies are surgical biopsy and needle biopsy. Surgical biopsy entails an incision to gather tissue samples and core needle biopsy is carried out in either hospitals and imaging centers. This biopsy is an image guided process. There are many benefits associated with such biopsies as the possibilities of sustaining an infection or a bruise are less. In case the lump is shown to be benign, then surgical biopsy will not be required. Although, there is a risk that the needle may not detect the tumor cells and as a result, one could misconstrue this as a non-cancerous cell.

Going by the segmentation of product, the market has been bifurcated into aspiration and biopsy needles. The segment for biopsy needles is anticipated to thrive at a very high CAGR during the forecast time frame because of the high presence of cancer and initiatives undertaken by certain healthcare facilities.

With end users, the market is fragmented into academic institutes, hospitals, research laboratories, imaging and diagnostic centers. The segment for hospital is projected to grow, in part, because of the developing healthcare framework in emerging nations, which shall inflate the aspiration and biopsy needles market size.



Among the prominent players in the market are:

Conmed Corporation, Medtronic Plc, Olympus, Becton, Dickinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Argon Medical Devices, Inc, INRAD Inc., Somatex Medical Technologies, Stryker Corporation.

Aspiration and Biopsy Needles Market Segmentation:

By Product Type Biopsy Needles

CNB Needles

VAB Needles

Aspiration Needles By Procedure Image-Guided Procedures

Non Image-Guided Procedures By Site Breast

Lung

Colorectal

Prostate

Kidney

Bone and Bone Marrow

Other Sites By End User Hospitals

Research & Academic Institutes

Diagnostic and Imaging Centers By Region Europe

North America

Asia Pacific

Latin America

Middle East & Africa FutureWise Key Takeaways: Growth prospects

SWOT analysis

Key trends

Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global aspiration & biopsy needles market by product type, by procedure, by site, by end user and by region.

To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

To evaluate and forecast micro-markets and the overall market

To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa

To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Profiling of companies to evaluate their market Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement

The customization Mobility Care offered are free of charge with purchase of any license of the report

You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com